Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of colestilan added to a calcium-based phosphate binder in dialysis patients with hyperphosphataemia
2006-003324-11Phase 3Terminated
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyperphosphatemia comparing colestilan + calcium-based phosphate binder with placebo + calcium-based phosphate binder (2 arms). Started Jan 2007; status: terminated.
02
Drugs
colestilan
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on 2006-003324-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003324-11.